{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:50:03Z","timestamp":1786981803821,"version":"build-2736575974"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,3,10]],"date-time":"2011-03-10T00:00:00Z","timestamp":1299715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11255-011-9929-6","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T01:09:32Z","timestamp":1299632972000},"page":"441-449","source":"Crossref","is-referenced-by-count":42,"title":["Allopurinol, uric acid, and oxidative stress in cardiorenal disease"],"prefix":"10.1007","volume":"43","author":[{"given":"Markus","family":"Riegersperger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,10]]},"reference":[{"issue":"5","key":"9929_CR1","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/ar2519","volume":"10","author":"AE Hak","year":"2008","unstructured":"Hak AE, Choi HK (2008) Menopause, postmenopausal hormone use and serum uric acid levels in US women\u2014the third national health and nutrition examination survey. Arthritis Res Ther 10(5):R116","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"9929_CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2133\/dmpk.23.263","volume":"23","author":"Y Li","year":"2008","unstructured":"Li Y, Sato M, Yanagisawa Y et al (2008) Effects of angiotensin II receptor blockers on renal handling of uric acid in rats. Drug Metab Pharmacokinet 23(4):263\u2013270","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"9929_CR3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.ajkd.2006.08.019","volume":"48","author":"ME Suliman","year":"2006","unstructured":"Suliman ME, Johnson RJ, Garcia-Lopez E et al (2006) J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis 48(5):761\u2013771","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"9929_CR4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1432-1033.1997.00541.x","volume":"245","author":"SA Sanders","year":"1997","unstructured":"Sanders SA, Eisenthal R, Harrison R (1997) NADH oxidase activity of human xanthine oxidoreductase. Eur J Biochem 245(3):541\u2013548","journal-title":"Eur J Biochem"},{"issue":"6","key":"9929_CR5","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/ard.42.6.684","volume":"42","author":"H Yamanaka","year":"1983","unstructured":"Yamanaka H, Nishioka K, Suzuki T et al (1983) Allopurinol metabolism in a patient with xanthine oidase deficiency. Ann Rheum Dis 42(6):684\u2013686","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"9929_CR6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/bjp.2008.343","volume":"155","author":"AAK El-Sheikh","year":"2008","unstructured":"El-Sheikh AAK, van den Heuvel JJMW, Koenderink JB et al (2008) Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4. Br J Pharmacol 155(7):1066\u20131075","journal-title":"Br J Pharmacol"},{"issue":"11","key":"9929_CR7","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","volume":"59","author":"HR Schumacher","year":"2008","unstructured":"Schumacher HR, Becker MA, Wortmann RL et al (2008) Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Rheum 59(11):1540\u20131548","journal-title":"Arthritis Rheum"},{"issue":"9","key":"9929_CR8","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1002\/art.23810","volume":"58","author":"JS Sundy","year":"2008","unstructured":"Sundy JS, Becker MA, Baraf HSB et al (2008) Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout. Arthritis Rheum 58(9):2882\u20132891","journal-title":"Arthritis Rheum"},{"issue":"11","key":"9929_CR9","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1002\/art.23993","volume":"58","author":"HSB Baraf","year":"2008","unstructured":"Baraf HSB, Matsumoto AK, Maroli AN et al (2008) Resolution of gouty tophi after twelve weeks of pegloticase treatment. Arthritis Rheum 58(11):3632\u20133634","journal-title":"Arthritis Rheum"},{"issue":"32","key":"9929_CR10","doi-asserted-by":"crossref","first-page":"14351","DOI":"10.1073\/pnas.1001072107","volume":"107","author":"MS Hershfield","year":"2010","unstructured":"Hershfield MS, Roberts LJI, Ganson NJ et al (2010) Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo. Proc Natl Acad Sci 107(32):14351\u201314356","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"9929_CR11","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/ndt\/gfg341","volume":"18","author":"J Chanard","year":"2003","unstructured":"Chanard J, Toupance O, Lavaud S et al (2003) Amlodipine reduces cyclosporin-induced hyperuricemia in hypertensive renal transplant recipients. Nephrol Dial Transpl 18(10):2147\u20132153","journal-title":"Nephrol Dial Transpl"},{"key":"9929_CR12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ahj.2004.04.005","volume":"148","author":"HJ Milionis","year":"2004","unstructured":"Milionis HJ, Kakafika AI, Tsouli SG et al (2004) Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J 148:635\u2013640","journal-title":"Am Heart J"},{"issue":"1","key":"9929_CR13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005344-199907000-00010","volume":"34","author":"M Elisaf","year":"1999","unstructured":"Elisaf M, Tsimichodimos V, Bairaktari E et al (1999) Effect of micronized fenofibrate and losartan combination on uric acid metabolism in hypertensive patients with hyperuricemia. J Cardiovasc Pharmacol 34(1):60\u201363","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"9929_CR14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2169\/internalmedicine.49.2597","volume":"49","author":"D Uetake","year":"2010","unstructured":"Uetake D, Ohno I, Ichida K et al (2010) Effect of fenofibrate on uric acid metabolism and urate transporter 1. Intern Med 49(2):89\u201394","journal-title":"Intern Med"},{"issue":"4","key":"9929_CR15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/106002808201600414","volume":"16","author":"CE Matheson","year":"1982","unstructured":"Matheson CE, Murphy JE, Gibson SH et al (1982) The effect of acute guafenesin administration on serum uric acid. Drug Intell Clin Pharm 16(4):332\u2013334","journal-title":"Drug Intell Clin Pharm"},{"issue":"1","key":"9929_CR16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1254\/jphs.10064SC","volume":"114","author":"M Nakamura","year":"2010","unstructured":"Nakamura M, Anzai N, Jutabha P et al (2010) Concentration-dependent inhibitory effect of irbesartan on renal uric acid transporters. J Pharmacol Sci 114(1):115\u2013118","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"9929_CR17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2169\/internalmedicine.48.1817","volume":"48","author":"I Ohno","year":"2009","unstructured":"Ohno I, Yamaguchi Y, Saikawa H et al (2009) Sevelamer decreases serum uric acid concentration through adsorption of uric acid in maintenance hemodialysis patients. Intern Med 48(6):415\u2013420","journal-title":"Intern Med"},{"issue":"4","key":"9929_CR18","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.juro.2007.11.062","volume":"179","author":"JC Lieske","year":"2008","unstructured":"Lieske JC, Regnier C, Dillon JJ (2008) Use of sevelamer hydrochloride as an oxalate binder. J Urol 179(4):1407\u20131410","journal-title":"J Urol"},{"issue":"3","key":"9929_CR19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1440-1797.2009.01249.x","volume":"15","author":"Y Shan","year":"2010","unstructured":"Shan Y, Zhang Q, Liu Z et al (2010) Prevalence and risk factors associated with chronic kidney disease in adults over 40\u00a0years: a population study from Central China. Nephrology 15(3):354\u2013361","journal-title":"Nephrology"},{"key":"9929_CR20","doi-asserted-by":"crossref","unstructured":"Lin CS, Hung YL, Chen GY et al. (2010) A multicenter study of the association of serum uric acid, serum creatinine, and diuretic use in hypertensive patients. Int J Cardiol. doi: 10.1016\/j.ijcard.2009.11.024","DOI":"10.1016\/j.ijcard.2009.11.024"},{"issue":"1","key":"9929_CR21","first-page":"66","volume":"32","author":"YC Chen","year":"2009","unstructured":"Chen YC, Su CT, Wang ST et al (2009) A preliminary investigation of the association between serum uric acid and impaired renal function. Chang Gung Med J 32(1):66\u201371","journal-title":"Chang Gung Med J"},{"issue":"6","key":"9929_CR22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/rheumatology\/keq095","volume":"49","author":"FC Kuo","year":"2010","unstructured":"Kuo FC, Yu KH, Luo SF et al (2010) Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional study. Rheumatology (Oxford) 49(6):1189\u20131196","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"9929_CR23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24164","volume":"61","author":"JH Chen","year":"2009","unstructured":"Chen JH, Chuang SY, Chen HJ et al (2009) Serum uric acid level as an independent risk factor for all-cause, cardivascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 61(2):225\u2013232","journal-title":"Arthritis Rheum"},{"issue":"15","key":"9929_CR24","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2169\/internalmedicine.49.3406","volume":"49","author":"Y Ohta","year":"2010","unstructured":"Ohta Y, Tsuchihashi T, Onaka U et al (2010) Clustering of cardiovascular risk factors and blood pressure control status in hypertensive patients. Intern Med 49(15):1483\u20131487","journal-title":"Intern Med"},{"issue":"6","key":"9929_CR25","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/ATVBAHA.107.160184","volume":"28","author":"C Meisinger","year":"2008","unstructured":"Meisinger C, Koenig W, Baumert J et al (2008) Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: The MONICA\/KORA cohort study. Arterioscler Thromb Vasc Biol 28(6):1186\u20131192","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"9929_CR26","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2337\/db09-0014","volume":"58","author":"P Hovind","year":"2009","unstructured":"Hovind P, Rossing P, Tarnow L et al (2009) Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes. Diabetes 58(7):1668\u20131671","journal-title":"Diabetes"},{"issue":"6","key":"9929_CR27","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2337\/dc10-0227","volume":"33","author":"LH Ficociello","year":"2010","unstructured":"Ficociello LH, Rosolowsky ET, Niewczas MA et al (2010) High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care 33(6):1337\u20131343","journal-title":"Diabetes Care"},{"issue":"9","key":"9929_CR28","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/dc09-0288","volume":"32","author":"S Kodama","year":"2009","unstructured":"Kodama S, Saito K, Yachi Y et al (2009) Association between serum uric acid and development of type 2 diabetes. Diabetes Care 32(9):1737\u20131742","journal-title":"Diabetes Care"},{"issue":"9","key":"9929_CR29","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.2337\/dc09-0625","volume":"32","author":"G Zoppini","year":"2009","unstructured":"Zoppini G, Targher G, Negri C et al (2009) Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care 32(9):1716\u20131720","journal-title":"Diabetes Care"},{"issue":"10","key":"9929_CR30","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2337\/dc09-0275","volume":"32","author":"CK Kramer","year":"2009","unstructured":"Kramer CK, von M\u00fchlen D, Jassal SK et al (2009) Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo study. Diabetes Care 32(10):1272\u20131273","journal-title":"Diabetes Care"},{"issue":"1","key":"9929_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.aje.a113972","volume":"121","author":"FN Brand","year":"1985","unstructured":"Brand FN, McGee DL, Kannel WB et al (1985) Hyperuricaemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol 121(1):11\u201318","journal-title":"Am J Epidemiol"},{"issue":"6","key":"9929_CR32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/CIRCHEARTFAILURE.108.797662","volume":"2","author":"E Krishnan","year":"2009","unstructured":"Krishnan E (2009) Hyperuricemia and incident heart failure. Circ Heart fail 2(6):556\u2013562","journal-title":"Circ Heart fail"},{"issue":"15","key":"9929_CR33","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archinternmed.2010.198","volume":"170","author":"G Thanassoulis","year":"2010","unstructured":"Thanassoulis G, Brophy JM, Richard H et al (2010) Gout, allopurinol use, and heart failure outcomes. Arch Intern Med 170(15):1358\u20131364","journal-title":"Arch Intern Med"},{"issue":"4","key":"9929_CR34","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1253\/circj.CJ-08-0626","volume":"73","author":"H Mitsuhashi","year":"2009","unstructured":"Mitsuhashi H, Yatsuya H, Matsushita K et al (2009) Uric acid and left ventricular hypertrophy in Japanese men. Circ J 73(4):667\u2013672","journal-title":"Circ J"},{"key":"9929_CR35","doi-asserted-by":"crossref","unstructured":"Hamaguchi S, Furumoto T, Tsuchihashi-Makaya M et al. (2010) Hyperuricemia predicts adverse outcomes in patients with heart failure. Int J Cardiol. doi: 10.1016\/j.ijcard.2010.05.002","DOI":"10.1016\/j.ijcard.2010.05.002"},{"issue":"3","key":"9929_CR36","first-page":"209","volume":"51","author":"KP Letsas","year":"2010","unstructured":"Letsas KP, Korantzopoulos P, Filippatos GS et al (2010) Uric acid elevation in atrial fibrillation. Hellenic J Cardiol 51(3):209\u2013213","journal-title":"Hellenic J Cardiol"},{"issue":"6","key":"9929_CR37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3325\/cmj.2009.50.559","volume":"50","author":"S Car","year":"2009","unstructured":"Car S, Trkulja V (2009) Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: retrospective prognostic study. Croat Med J 50(6):559\u2013566","journal-title":"Croat Med J"},{"issue":"6","key":"9929_CR38","first-page":"605","volume":"32","author":"TH Tsai","year":"2009","unstructured":"Tsai TH, Chen YC, Chen SM et al (2009) Uric acid is not an indendent predictor of cardiovascular death in patients with angiographically proven coronary artery disease. Chang Gung Med J 32(6):605\u2013613","journal-title":"Chang Gung Med J"},{"issue":"5","key":"9929_CR39","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1253\/circj.CJ-08-0828","volume":"73","author":"T Okura","year":"2009","unstructured":"Okura T, Higaki J, Kurata M et al (2009) Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis. Circ J 73(5):885\u2013891","journal-title":"Circ J"},{"issue":"4","key":"9929_CR40","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/j.ajkd.2004.06.006","volume":"44","author":"K Iseki","year":"2004","unstructured":"Iseki K, Ikemiya Y, Inoue T et al (2004) Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 44(4):642\u2013650","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"9929_CR41","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1681\/ASN.2008010080","volume":"19","author":"RP Obermayr","year":"2008","unstructured":"Obermayr RP, Temml C, Gutjahr G et al (2008) Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 19(12):2407\u20132413","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"9929_CR42","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/ar2775","volume":"11","author":"D Daoussis","year":"2009","unstructured":"Daoussis D, Panoulas V, Toms T et al (2009) Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther 11(4):R116","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"9929_CR43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/TP.0b013e3181c73c18","volume":"89","author":"A Haririan","year":"2010","unstructured":"Haririan A, Noguiera JM, Zandi-Nejad K et al (2010) The independent association between serum uric acid and graft outcomes after kidney transplantation. Transplantation 89(5):573\u2013579","journal-title":"Transplantation"},{"issue":"6","key":"9929_CR44","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.metabol.2008.01.030","volume":"57","author":"X Sui","year":"2008","unstructured":"Sui X, Church TS, Meriwether RA et al (2008) Uric acid and the development of metabolic syndrome in women and men. Metabolism 57(6):845\u2013852","journal-title":"Metabolism"},{"issue":"5","key":"9929_CR45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/10641960903265220","volume":"32","author":"S Seki","year":"2010","unstructured":"Seki S, Tsutsui K, Fujii T et al (2010) Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension. Clin Exp Hypertens 32(5):270\u2013277","journal-title":"Clin Exp Hypertens"},{"key":"9929_CR46","doi-asserted-by":"crossref","unstructured":"Ho WJ, Tsai WP, Yu KH et al. (2010) Association between endothelial dysfunction and hyperuricaemia. Rheumatology. Online only","DOI":"10.1093\/rheumatology\/keq184"},{"issue":"2","key":"9929_CR47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.atherosclerosis.2007.12.023","volume":"200","author":"F Khan","year":"2007","unstructured":"Khan F, George J, Wong K et al (2007) The association between serum urate levels and arterial stiffness\/endothelial function in stroke survivors. Atherosclerosis 200(2):374\u2013379","journal-title":"Atherosclerosis"},{"issue":"3","key":"9929_CR48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5551\/jat.1594","volume":"17","author":"S Kuwahata","year":"2010","unstructured":"Kuwahata S, Hamasaki S, Ishada S et al (2010) Effect of uric acid on coronary microvascular endothelial function in women: association with eGFR and ADMA. J Atheroscler Thromb 17(3):259\u2013269","journal-title":"J Atheroscler Thromb"},{"issue":"8","key":"9929_CR49","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/15257770802257952","volume":"27","author":"C Gersch","year":"2008","unstructured":"Gersch C, Palii SP, Kim KM et al (2008) Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids 27(8):967\u2013978","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"1","key":"9929_CR50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1523-1755.1999.00229.x","volume":"55","author":"T Heitzer","year":"1999","unstructured":"Heitzer T, Wenzel U, Hink U et al (1999) Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 55(1):252\u2013260","journal-title":"Kidney Int"},{"issue":"2","key":"9929_CR51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00411-006-0090-z","volume":"46","author":"KG Soucy","year":"2007","unstructured":"Soucy KG, Lim HK, Benjo A et al (2007) Single-exposure gamma-irradiation amplifies xanthine oxidase activity and induces endothelial dysfunction in rat aorta. Radiat Environ Biophys 46(2):179\u2013186","journal-title":"Radiat Environ Biophys"},{"issue":"4","key":"9929_CR52","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1152\/ajprenal.00104.2008","volume":"295","author":"LG Sanchez-Lozada","year":"2008","unstructured":"Sanchez-Lozada LG, Soto V, Tapia E et al (2008) Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol 295(4):1134\u20131141","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"9929_CR53","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1152\/ajpheart.00831.2005","volume":"290","author":"AV Naumova","year":"2005","unstructured":"Naumova AV, Chacko VP, Ouwerkerk R et al (2005) Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts. Am J Physiol Heart Circ Physiol 290(6):837\u2013843","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"9929_CR54","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1152\/ajpregu.00436.2005","volume":"290","author":"E Daghini","year":"2005","unstructured":"Daghini E, Chade AR, Krier JD et al (2005) Acute inhibition of the endogenous xanthine oxidase improved renal hemodynamics in hypercholesterolemic pigs. Am J Physiol Reul Integr Comp Physiol 290(3):609\u2013615","journal-title":"Am J Physiol Reul Integr Comp Physiol"},{"issue":"2","key":"9929_CR55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1152\/ajprenal.00092.2009","volume":"297","author":"T Kosugi","year":"2009","unstructured":"Kosugi T, Nakayama T, Heinig M et al (2009) Effect of lowering uric acid on renal disease in type 2 diabetic db\/db mice. Am J Physiol Renal Physiol 297(2):481\u2013488","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"9929_CR56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.HYP.30.1.57","volume":"30","author":"C Cardillo","year":"1997","unstructured":"Cardillo C, Kilcoyne CM, Cannon RO et al (1997) Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not hypertensive patients. Hypertension 30(1):57\u201363","journal-title":"Hypertension"},{"issue":"8","key":"9929_CR57","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","volume":"300","author":"DI Feig","year":"2007","unstructured":"Feig DI, Soletsky B, Johnson RJ (2007) Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 300(8):924\u2013932","journal-title":"JAMA"},{"issue":"6","key":"9929_CR58","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/hrt.2004.040477","volume":"91","author":"AD Gavin","year":"2004","unstructured":"Gavin AD, Struthers AD (2004) Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure. Heart 91(6):749\u2013753","journal-title":"Heart"},{"issue":"9","key":"9929_CR59","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1742-1241.2009.02118.x","volume":"63","author":"L Wei","year":"2009","unstructured":"Wei L, Fahey T, Struthers AD et al (2009) Association between allopurinol and mortality in heart failure patients: a long-term follow-up study. J Clin Pract 63(9):1327\u20131333","journal-title":"J Clin Pract"},{"issue":"8","key":"9929_CR60","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.freeradbiomed.2006.07.010","volume":"41","author":"S Baldus","year":"2006","unstructured":"Baldus S, M\u00fcllerleile K, Chumley P et al (2006) Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy. Free Radic Biol Med 41(8):1282\u20131288","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"9929_CR61","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00005344-200305000-00005","volume":"41","author":"W Guan","year":"2003","unstructured":"Guan W, Osanai T, Kamada T et al (2003) Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction. J Cardiovasc Pharmacol 41(5):699\u2013705","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9","key":"9929_CR62","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.freeradbiomed.2005.06.004","volume":"39","author":"S Baldus","year":"2005","unstructured":"Baldus S, K\u00f6ster R, Chumley P et al (2005) Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med 39(9):1184\u20131190","journal-title":"Free Radic Biol Med"},{"issue":"9749","key":"9929_CR63","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(10)60391-1","volume":"357","author":"A Noman","year":"2010","unstructured":"Noman A, Ang DSC, Ogston S et al (2010) Effect of high-dose allopurinol on exercise in patients with chronic stable agina: a randomised, placebo controlled crossover trial. Lancet 357(9749):2161\u20132167","journal-title":"Lancet"},{"issue":"4","key":"9929_CR64","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.ATV.0000258415.32883.bf","volume":"27","author":"U Landmesser","year":"2007","unstructured":"Landmesser U, Spiekermann S, Preuss C et al (2007) Angiotensin II induces endothelial xanthine oxidase activation\u2014role for endothelial dysfunction in patients with coronary disease. Arterioscler Thromb Vasc Biol 27(4):943\u2013948","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"9929_CR65","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","volume":"5","author":"M Goicoechea","year":"2010","unstructured":"Goicoechea M, Garcia de Vinuesa S, Verdalles U et al (2010) Effect of allopurinol on chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5(8):1388\u20131393","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"9929_CR66","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11255-007-9253-3","volume":"39","author":"M Kanbay","year":"2007","unstructured":"Kanbay M, Ozkara A, Selcoki Y et al (2007) Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal function. Int Urol Nephrol 39(4):1227\u20131233","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"9929_CR67","first-page":"385","volume":"9","author":"B Shelmadine","year":"2009","unstructured":"Shelmadine B, Bowden RG, Wilson RL et al (2009) The effect of lowering uric acid levels using allurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study. Anadolu Kardiyol Derg 9(5):385\u2013389","journal-title":"Anadolu Kardiyol Derg"},{"issue":"11","key":"9929_CR68","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames BN, Cathcart R, Schwiers E et al (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78(11):6858\u20136862","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9929_CR69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0021-9150(99)00214-2","volume":"148","author":"FJ Nieto","year":"2000","unstructured":"Nieto FJ, Iribarren C, Gross MD et al (2000) Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 148(1):131\u2013139","journal-title":"Atherosclerosis"},{"issue":"6","key":"9929_CR70","first-page":"485","volume":"16","author":"AJ Reyes","year":"2002","unstructured":"Reyes AJ, Leary WP (2002) The ALLHAT and the cardioprotection conferred by diuretics in hypertensive patients: a connection with uric acid? Cardiovasc Drugs Ther 16(6):485\u2013487","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"9929_CR71","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","volume":"26","author":"DB Corry","year":"2008","unstructured":"Corry DB, Eslami P, Yamamoto K et al (2008) Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 26(2):269\u2013275","journal-title":"J Hypertens"},{"issue":"6","key":"9929_CR72","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","volume":"41","author":"J Kanellis","year":"2003","unstructured":"Kanellis J, Watanabe S, Li HJ et al (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41(6):1287\u20131293","journal-title":"Hypertension"},{"issue":"3","key":"9929_CR73","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.59.3.347","volume":"59","author":"H Goldblatt","year":"1934","unstructured":"Goldblatt H, Lynch J, Hanzal RF et al (1934) The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59(3):347\u2013379","journal-title":"J Exp Med"},{"issue":"12","key":"9929_CR74","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1681\/ASN.2005050572","volume":"16","author":"DH Kang","year":"2005","unstructured":"Kang DH, Park SK, Lee IK et al (2005) Uric acid induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16(12):3553\u20133562","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"9929_CR75","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.HYP.0000228320.23697.29","volume":"48","author":"DL Mattson","year":"2006","unstructured":"Mattson DL, James L, Berdan EA et al (2006) Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 48(1):149\u2013156","journal-title":"Hypertension"},{"issue":"3","key":"9929_CR76","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1983.tb00205.x","volume":"10","author":"MB Walker","year":"1983","unstructured":"Walker MB, Boyd GW (1983) The distribution of arteriolosclerosis along the arterioles in DOCA hypertensive rats. Clin Exp Pharmacol Physiol 10(3):319\u2013323","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"9929_CR77","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00074.x","volume":"67","author":"LG Sanchez-Lozada","year":"2005","unstructured":"Sanchez-Lozada LG, Tapia E, Santamaria J et al (2005) Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 67(1):237\u2013247","journal-title":"Kidney Int"},{"issue":"5","key":"9929_CR78","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"UM Khosla","year":"2005","unstructured":"Khosla UM, Zharikov S, Finch JL et al (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67(5):1739\u20131742","journal-title":"Kidney Int"},{"issue":"5","key":"9929_CR79","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/ajpcell.00075.2008","volume":"295","author":"S Zharikov","year":"2008","unstructured":"Zharikov S, Krotova K, Hu H et al (2008) Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol 295(5):1183\u20131190","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7","key":"9929_CR80","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/00007890-200104150-00014","volume":"71","author":"M Mazzali","year":"2001","unstructured":"Mazzali M, Kim YG, Suga S et al (2001) Hyperuricemia exacerbates chronic cyclosporine nephropathy. Transplantation 71(7):900\u2013905","journal-title":"Transplantation"},{"issue":"4, Pt. 2","key":"9929_CR81","first-page":"596","volume":"260","author":"CH Hsu","year":"1991","unstructured":"Hsu CH, Patel SR, Young EW et al (1991) Effects of purine derivatives on calcitriol metabolism in rats. Am J Physiol 260(4, Pt. 2):596\u2013601","journal-title":"Am J Physiol"},{"issue":"4","key":"9929_CR82","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.V441035","volume":"4","author":"R Vanholder","year":"1993","unstructured":"Vanholder R, Patel S, Hsu CH (1993) Effect of uric acid on plasma levels on plasma levels of 1, 25(OH)2D in renal failure. J Am Soc Nephrol 4(4):1035\u20131038","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"9929_CR83","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1152\/ajpregu.00821.2007","volume":"294","author":"KR Pechman","year":"2008","unstructured":"Pechman KR, Basile DP, Lund H et al (2008) Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure. Am J Physiol Regul Integr Comp Physiol 294(4):1234\u20131239","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"9929_CR84","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1152\/ajpregu.91022.2008","volume":"297","author":"KR Pechman","year":"2009","unstructured":"Pechman KR, De Miguel C, Lund H et al (2009) Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodium-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 297(5):1358\u20131363","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"9929_CR85","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3904\/kjim.2010.25.1.21","volume":"25","author":"HE Lim","year":"2010","unstructured":"Lim HE, Kim SH, Kim EJ et al (2010) Clinical value of serum uric acid in patients with suspected coronary artery disease. Korean J Intern Med 25(1):21\u201326","journal-title":"Korean J Intern Med"},{"issue":"4","key":"9929_CR86","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1536\/ihj.50.407","volume":"50","author":"SA Sakr","year":"2009","unstructured":"Sakr SA, Abbas TM, Amer MZ et al (2009) Microvascular angina. The possible role of inflammation, uric acid, and endothelial dysfunction. Int Heart J 50(4):407\u2013419","journal-title":"Int Heart J"},{"issue":"7","key":"9929_CR87","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4070\/kcj.2010.40.7.314","volume":"40","author":"JH Lim","year":"2010","unstructured":"Lim JH, Kim YK, Kim YS et al (2010) Relationship between serum uric acid levels, metabolic syndrome, and arterial stiffness in korean. Korean Circ J 40(7):314\u2013320","journal-title":"Korean Circ J"},{"issue":"1","key":"9929_CR88","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3325\/cmj.2010.51.48","volume":"51","author":"O Polasek","year":"2010","unstructured":"Polasek O, Gunjaca G, Kolcic I et al (2010) Association of nephrolithiasis and gene for glucose transporter type 9 (SLC2A9): study of 145 patients. Croat Med J 51(1):48\u201353","journal-title":"Croat Med J"},{"issue":"11","key":"9929_CR89","doi-asserted-by":"crossref","first-page":"e7729","DOI":"10.1371\/journal.pone.0007729","volume":"4","author":"K Stark","year":"2009","unstructured":"Stark K, Reinhard W, Grassl M et al (2009) Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLoS One 4(11):e7729","journal-title":"PLoS One"},{"issue":"6","key":"9929_CR90","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000195632","volume":"29","author":"CC Hung","year":"2009","unstructured":"Hung CC, Liu WC, Kuo MC et al (2009) Acute renal failure and its risk factors in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Am J Nephrol 29(6):633\u2013638","journal-title":"Am J Nephrol"},{"issue":"4","key":"9929_CR91","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2125.1996.03116.x","volume":"41","author":"S Graham","year":"1996","unstructured":"Graham S, Day RO, Wong H et al (1996) Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects. Br J Clin Pharmacol 41(4):299\u2013304","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"9929_CR92","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2125.1988.tb03402.x","volume":"26","author":"RO Day","year":"1988","unstructured":"Day RO, Miners JO, Birkett DJ et al (1988) Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol. Br J Clin Pharmacol 26(4):429\u2013434","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"9929_CR93","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","volume":"76","author":"KR Hande","year":"1984","unstructured":"Hande KR, Noone RM, Stone WJ (1984) Severe allopurinol toxicity: description and guidelines for prevention in patients with renal insufficiency. Am J Med 76(1):47\u201356","journal-title":"Am J Med"},{"issue":"41","key":"9929_CR94","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.683831","volume":"115","author":"JT Kielstein","year":"2007","unstructured":"Kielstein JT, Woywodt A, Salpeter SR (2007) Letter to the Editor. Circulation 115(41):450\u2013451","journal-title":"Circulation"},{"issue":"6","key":"9929_CR95","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1152\/ajprenal.00283.2001","volume":"282","author":"M Mazzali","year":"2002","unstructured":"Mazzali M, Kanellis J, Han L et al (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure independent mechanism. Am J Physiol Renal Physiol 282(6):991\u2013997","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"9929_CR96","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.HYP.0000120971.49659.6a","volume":"43","author":"T Mori","year":"2004","unstructured":"Mori T, Cowley AW Jr (2004) Role of pressure in angiotensin II induced renal injury: chronic servo-control of renal perfusion in rats. Hypertension 43(4):752\u2013759","journal-title":"Hypertension"},{"issue":"6","key":"9929_CR97","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/01.HYP.31.6.1331","volume":"31","author":"EJ Su","year":"1998","unstructured":"Su EJ, Lombardi DM, Siegal J et al (1998) Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure. Hypertension 31(6):1331\u20131337","journal-title":"Hypertension"},{"issue":"4","key":"9929_CR98","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000321074","volume":"30","author":"M Kanbay","year":"2010","unstructured":"Kanbay M, Solak Y, Dogan E et al (2010) Uric acid in hypertension and renal disease: the chicken or the egg? Blood Purif 30(4):288\u2013295","journal-title":"Blood Purif"},{"issue":"2","key":"9929_CR99","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/ndt\/gfq635","volume":"26","author":"M Kanbay","year":"2010","unstructured":"Kanbay M, Sanchez-Lozada LG, Franco M et al (2010) Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin. Nephrol Dial Transplant 26(2):430\u2013437","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"9929_CR100","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/j.ajkd.2009.06.024","volume":"54","author":"F Turgut","year":"2009","unstructured":"Turgut F, Kasapoglu B, Kanbay M (2009) Uric acid, cardiovascular mortality, and long-term outcomes in CKD. Am J Kidney Dis 54(3):582\u2013583","journal-title":"Am J Kidney Dis"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-011-9929-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-011-9929-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-011-9929-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T23:39:32Z","timestamp":1637365172000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-011-9929-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,10]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["9929"],"URL":"https:\/\/doi.org\/10.1007\/s11255-011-9929-6","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,10]]}}}